NCT02042066View on ClinicalTrials.gov

Safety and Efficacy Study of Extracorporeal Shockwave Therapy in the Treatment of Patients With Resistant Hypertension

PHASE1UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Conditions
Hypertension, Resistant to Conventional Therapy
Interventions
DEVICE

Omnispec model Vascuspec

Energy Density: 0.09 - 0.1 mJ/mm2 Extracorporeal Shockwave Therapy

Trial Locations (1)

91120

Hadassah Medical Organization, Jerusalem

Sponsors

Lead Sponsor

Medispec
All Listed Sponsors
collaborator

Hadassah Medical Organization

OTHER

lead

Medispec

INDUSTRY